Chief Medical Officer, The Janssen Pharmaceutical Companies of Johnson & Johnson.
Aran Maree, M.D., serves as Chief Medical Officer (CMO) for Johnson & Johnson’s pharmaceuticals group. In this role, Dr. Maree advocates for patients across the organization and champions ethical, evidence-based, patient-centric decision-making. Johnson & Johnson, the world’s most comprehensive and broadly-based manufacturer of healthcare products, has 127,000 employees who touch the lives of more than one billion people daily.
As the CMO Dr. Maree’s Global Medical Organization has responsibility for ensuring the safe, effective and appropriate use of the company’s 1,000+ pharmaceutical products. In addition, his group oversees patient safety during the development of new medicines, and advocates for evidence-based and ethical policies to enhance access to investigational medicines and improve public health.
He also leads groups responsible for the independent assessment of medical benefits and risks for all Janssen medicines, including biologics and vaccines, through the life of the medicine, from first human exposure through all phases of clinical research, launch and all market activity.
Dr. Maree serves on the R&D leadership team, which is responsible for driving Janssen’s research portfolio across multiple areas of serious unmet patient need, and leads special patient focus areas such as pre-approval access. In addition, he chairs the senior governance body at Janssen responsible for decision-making on patient safety.
Among his prior roles at Johnson & Johnson, Dr. Maree served as Chief Medical Officer for the Medical Devices group as well as Vice President for Strategic Medical Affairs for Asia-Pacific and Japan. Prior to joining Johnson & Johnson, he worked in regional roles in Asia Pacific at Merck & Co. and at The Boston Consulting Group.
Dr. Maree graduated with honors from the Royal College of Surgeons in Ireland (National University of Ireland), is a Member of the Royal College of Physicians of Ireland, and received training in general medicine and interventional cardiology in Dublin, Ireland, and Sydney, Australia. He holds dual Irish and Australian citizenship.
Dr. Maree combines broad global experience in medical technology and innovative pharmaceuticals with a passion for patient safety and ethical leadership in healthcare.
Aran Maree will speak in Session 3 “The Future of Work”.